About this trial
Spleen could have been surgically removed for trauma, cancer, auto-immune disease, or to perform a diagnosis. Spleen could be non-functional due to radiotherapy or splenic artery embolism. These patients are at risks of infectious diseases due to encapsulated bacteria, cancer, and thromboembolism disease. The purpose of this study is to assess complications occurring in French patients without spleen and to implement new diagnostic tools for follow-up.
Eligibility criteria
Qualifiers
≥18 year-old
With asplenia due to splenectomy, splenic artery embolization or radiotherapy
Disqualifiers
Genetic asplenia including sick cell disease
Trial design
Treatments tested in this trial
- Not listed
Trial groups
Sponsors and collaborators
Poitiers University Hospital
Lead sponsor
Pr Pierre BUFFET Institut National de la Transfusion Sanguine
Collaborator
Dr Edouard TUAILLON Département Bactériologie-Virologie/INSERM U1058 CHU de Montpellier
Collaborator